MediWound MDWD
NASDAQ MDWD
$13.73 -0.11 (-0.79%)
As of: Sep 10, 2026 · 3:59 PM EDT

MediWound (MDWD) Non Operating Interest Expenses (2013 - 2026)

MediWound (MDWD) posted Non Operating Interest Expenses of -$1.1 million for Q2 2026, up 54.52% on a QoQ basis from -$2.5 million in Q4 2025, and up 85.98% year-over-year from -$602768.4 in Q2 2025.

Analysis

MediWound (MDWD) Non Operating Interest Expenses (2013 - 2026) Analysis & Trends

MediWound has reported Non Operating Interest Expenses for 14 years, with the latest figure at -$1.1 million in Q2 2026.

  • On a quarterly basis, Non Operating Interest Expenses rose 85.98% year-over-year to -$1.1 million in Q2 2026; TTM through Jun 2026 was -$7.6 million, a 32.75% increase from a year earlier, with the FY2025 full-year figure at -$2.5 million, up 80.79% from the prior year.
  • Non Operating Interest Expenses was -$1.1 million for Q2 2026 at MediWound, up from -$2.5 million in the prior quarter.
  • The five-year high for Non Operating Interest Expenses was $4.0 million in Q3 2025, with the low at -$8.0 million in Q2 2025.
  • Average Non Operating Interest Expenses over 5 years is -$1.1 million, with a median of -$781000.0 recorded in 2022.
  • The sharpest annual moves came in 2022 and 2025: Non Operating Interest Expenses soared 159.06% in 2022, then slumped 232.35% in 2025.
  • Over 5 years, Non Operating Interest Expenses stood at $375000.0 in 2022, then slumped by 338.13% to -$893000.0 in 2023, then slumped by 169.32% to -$2.4 million in 2024, then decreased by 2.49% to -$2.5 million in 2025, then surged by 54.52% to -$1.1 million in 2026.
  • The last three Non Operating Interest Expenses figures came in at -$1.1 million (Q2 2026), -$2.5 million (Q4 2025), and $4.0 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 673.00 Mn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 247.00 Mn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 11.00 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -1.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 82.05 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 MediWound 156.09 Mn 120.75 Mn 337,000.00 -1.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.12 Mn
Dec 31, 2025 -2.47 Mn
Sep 30, 2025 3.99 Mn
Jun 30, 2025 -7.99 Mn
Mar 31, 2025 4,000.00
Jun 30, 2024 -2.41 Mn
Jun 30, 2023 -893,000.00
Dec 31, 2022 375,000.00
Sep 30, 2022 -781,000.00
Jun 30, 2022 -687,000.00
Mar 31, 2022 -440,000.00
Dec 31, 2021 -635,000.00
Sep 30, 2021 -457,000.00
Jun 30, 2021 -399,000.00
Mar 31, 2021 -941,000.00
Dec 31, 2020 657,000.00
Sep 30, 2020 -541,000.00
Jun 30, 2020 -491,000.00
Mar 31, 2020 -494,000.00
Dec 31, 2019 -382,000.00